219 results on '"Coltrini, Daniela"'
Search Results
2. Cannabidiol alters mitochondrial bioenergetics via VDAC1 and triggers cell death in hormone-refractory prostate cancer
3. FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer
4. Vitreous from idiopathic epiretinal membrane patients induces glial-to-mesenchymal transition in Müller cells
5. Gene expression analysis identifies two distinct molecular clusters of idiopatic epiretinal membranes
6. d-Peptide analogues of Boc-Phe-Leu-Phe-Leu-Phe-COOH induce neovascularization via endothelial N-formyl peptide receptor 3
7. Supplementary Figure 1 from Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells
8. Supplementary Figure 3 from Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells
9. Data from Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone–Regulated Tumors
10. Supplementary Figure Legend from Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells
11. Supplementary Figure 4 from Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells
12. Supplementary Table 1 from Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells
13. Data from Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells
14. Supplementary Figures 1-5 from Long Pentraxin-3 Inhibits FGF8b-Dependent Angiogenesis and Growth of Steroid Hormone–Regulated Tumors
15. Supplementary Figure 2 from Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells
16. Figure S4 from Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer
17. Supplementary Fig. S1 from αvβ3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers
18. Data from αvβ3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers
19. Supplementary Data from β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism
20. Data from Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer
21. Supplementary Data from Antiangiogenic Activity of a Neutralizing Human Single-Chain Antibody Fragment against Fibroblast Growth Factor Receptor 1
22. Data from Antiangiogenic Activity of a Neutralizing Human Single-Chain Antibody Fragment against Fibroblast Growth Factor Receptor 1
23. Supplementary Materials and Methods from Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer
24. Supplementary Mathematical Model from Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer
25. Supplementary Tables from Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer
26. Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy
27. Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy
28. β-Galactosylceramidase Deficiency Causes Upregulation of Long Pentraxin-3 in the Central Nervous System of Krabbe Patients and Twitcher Mice
29. Istologia Umana
30. Brain angioarchitecture and intussusceptive microvascular growth in a murine model of Krabbe disease
31. Basic Fibroblast Growth Factor Expression in Endothelial Cells: An Autocrine Role in Angiogenesis?
32. Human Basic Fibroblast Growth Factor: Structure-Function Relationship of an Angiogenic Molecule
33. An Orthotopic Model of Uveal Melanoma in Zebrafish Embryo: A Novel Platform for Drug Evaluation
34. Matrigel plug assay: evaluation of the angiogenic response by reverse transcription-quantitative PCR
35. Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor
36. Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy
37. Long pentraxin-3 as an epithelial–stromal fibroblast growth factor-targeting inhibitor in prostate cancer
38. β-Galactosylceramidase Promotes Melanoma Growth via Modulation of Ceramide Metabolism
39. Natural killer cell impairment in ovarian clear cell carcinoma
40. Modeling Acquired Resistance to the Second-Generation Androgen Receptor Antagonist Enzalutamide in the TRAMP Model of Prostate Cancer
41. Endothelial cells overexpressing basic fibroblast growth factor (FGF-2) induce vascular tumors in immunodeficient mice
42. Cardiac Microvascular Endothelial Cells Express a Functional Ca2+-Sensing Receptor
43. FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer.
44. Distinct Role of Fibroblast Growth Factor-2 and Vascular Endothelial Growth Factor on Tumor Growth and Angiogenesis
45. β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease
46. From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies
47. Upregulation of urokinase-type plasminogen activator by endogenous and exogenous HIV-1 Tat protein in tumour cell lines derived from BK virus/tat-transgenic mice
48. Fibroblast Growth Factor-2 Antagonist Activity and Angiostatic Capacity of Sulfated Escherichia coli K5 Polysaccharide Derivatives
49. lnvolvement of N-formyl peptide receptors in modulating the pro-angiogenic pro-inflammatory activity of human vitreous in proliferative diabetic retinopathy (POR)
50. Fibroblast growth factor modulates mast cell recruitment in a murine model of prostate cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.